key: cord-0770919-mme96iuz authors: Yang, Jing; Li, Juan; Lai, Shengjie; Ruktanonchai, Corrine W; Xing, Weijia; Carioli, Alessandra; Wang, Peihan; Ruktanonchai, Nick W; Li, Ruiyun; Floyd, Jessica R; Wang, Liang; Bi, Yuhai; Shi, Weifeng; Tatem, Andrew J title: Uncovering two phases of early intercontinental COVID-19 transmission dynamics date: 2020-10-22 journal: J Travel Med DOI: 10.1093/jtm/taaa200 sha: a9bc6bd1a7fc6154b46a7f0d4061e30ebc70ae5e doc_id: 770919 cord_uid: mme96iuz Background: The COVID-19 pandemic has posed an ongoing global crisis, but how the virus spread across the world remains poorly understood. This is of vital importance for informing current and future pandemic response strategies. Methods: We performed two independent analyses, travel network-based epidemiological modelling and Bayesian phylogeographic inference, to investigate the intercontinental spread of COVID-19. Results: Both approaches revealed two distinct phases of COVID-19 spread by the end of March 2020. In the first phase, COVID-19 largely circulated in China during mid- to late January, 2020, and was interrupted by containment measures in China. In the second and predominant phase extending from late February to mid-March, unrestricted movements between countries outside of China facilitated intercontinental spread, with Europe as a major source. Phylogenetic analyses also revealed that the dominant strains circulating in the United States of America were introduced from Europe. However, stringent restrictions on international travel across the world since late March have substantially reduced intercontinental transmission. Conclusions: Our analyses highlight that heterogeneities in international travel have shaped the spatiotemporal characteristics of the pandemic. Unrestricted travel caused a large number of COVID-19 exportations from Europe to other continents between late February and mid-March, which facilitated the COVID-19 pandemic. Targeted restrictions on international travel from countries with widespread community transmission, together with improved capacity in testing, genetic sequencing and contact tracing, can inform timely strategies for mitigating and containing COVID-19 outbreaks post-lockdown. The coronavirus disease 2019 , caused by the highly contagious causative agent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first identified in Wuhan, Hubei province, in late 2019. 1, 2 The World Health Organization declared COVID-19 a pandemic on March 11, 2020. As of October 1, 2020, there have been more than 33 million confirmed COVID-19 cases with 1.01 million fatalities worldwide, affecting more than 200 countries, territories or areas. 3 Non-pharmaceutical interventions are currently the only viable strategies available to contain and suppress COVID-19 spread, 4-6 especially for the travel-associated spread between and within countries. [7] [8] [9] [10] [11] [12] [13] For example, Wuhan's lockdown on January 23, 2020 delayed the growth and limited the size of the COVID-19 outbreak in China. [7] [8] [9] These travel restrictions also had an effect in reducing international transmission of SARS-CoV-2, with a 77% reduction in cases exported from mainland China to other countries. 10, 11 Accordingly, epidemics triggered by international importations in multiple countries have been suppressed by substantial travel and social distancing interventions. 12, 13 However, widespread community transmission of SARS-CoV-2 was still reported in some regions after easing these measures, with an increase in confirmed cases or subnational localized resurgences in the United States of America (USA), India, Japan, and some European countries since late June. 14, 15 Studies have attempted to quantify the spread risk of COVID-19 using epidemiological models within a country and at regional scales, 5, 10, [16] [17] [18] and accumulated divergences among genomic data of SARS-CoV-2 have also been used to trace the viral spread. For instance, it was found that most of the SARS-CoV-2 strains circulating in the New York area and Northern California were introduced from Europe via multiple independent importation events. 19, 20 Similarly, the great majority of the SARS-CoV-2 strains circulating in UK were derived from continental Europe in March via inbound travellers. 21 The effects of international travel and border control measures on the global spread of SARS-CoV-2 were also preliminarily explored. 10 Using domestic and international population mobility data and a susceptible-exposed-infectious-removed (SEIR) framework, 6 24 We also used initial epidemiological information (i.e. the incubation period and delays from symptom onset to report) estimated from case data during the early stages of the outbreak in Wuhan. 25 Additionally, two mobile phone-derived publicly available anonymized population mobility datasets covering 133 countries, territories or areas in 2020 26, 27 All available complete or near-complete genomic nucleotide sequences of SARS-CoV-2 were collected from GISAID (https://www.gisaid.org), NCBI GenBank To investigate the global phylodynamics of SARS-CoV-2, phylogeographic inferences were performed using the asymmetric discrete trait analysis in BEAST v1.10.4 (Supplementary Materials and Methods). 29 We employed the general time reversible (GTR) nucleotide substitution model and a model to account for rate heterogeneity across sites by combining the discrete gamma distribution with four rate categories and invariable-sites. A strict molecular clock was utilized to model sequence evolution. Two tree priors, exponential growth and Bayesian skyline, were employed to describe virus population dynamics. By evaluating the marginal likelihood and evolutionary rate estimates, the exponential growth model was selected in subsequent analyses. Also, we set up Markov jump count parameters to obtain the frequency of transitions between location traits along phylogenetic branches over time (https://beast.community/markov_jumps_rewards). Analyses with the same parameter configuration were performed on 14 subsampled datasets to assess the robustness of phylogeographic inferences. We performed each analysis with 100 million iterations, later removing an appropriate burn-in (10%-40% of samples) to get an adequate effective sample size (basically ESS ≥100). The maximum clade credibility (MCC) tree was calculated from the posterior tree space in TreeAnnotator v1.10.4. To Analogously, type S was further divided into S1 (18060C, 17858, and 17747) and S2 (18060T, 17858G, and 17747T). The numbering of nucleotide sites is referred to the NCBI reference sequence of SARS-CoV-2, NC_045512. Further, SARS-CoV-2 strains isolated from the USA by May 20, 2020 were classified into different lineages. The distributions of different virus lineage within each state of the USA were summarized. Figures 1, 2) . Additionally, our estimated epicurves were consistent with the patterns seen for reported curves as of March 31, 2020 (p<0.001, R 2 =0.96), and high correlations were also found between the reported data and the estimated incidence by country (p<0.001, R 2 =0.70) and estimated imported cases from China (p<0.001, R 2 =0.65), respectively (Supplementary Figures 4, 5) . We summarized the Markov jumps between defined locations in the phylogenies of the posterior tree space to describe the intercontinental transmissions of SARS-CoV-2, and the inferred phylodynamics of SARS-CoV-2 from 14 sub-sampling datasets are consistent and robust. Consistent with results from the SEIR modelling ( Figure 1A) , two peaks of global SARS-CoV-2 transmission were also identified by Bayesian phylogeographic inference ( Figure 1B ). The first peak of virus dissemination occurred during mid-to late January 2020, but shortly after the Wuhan shutdown, viral transmission from China reduced dramatically. The second peak, which was higher than the first, occurred around early to mid-March and decreased rapidly after March 15. The Bayesian inference also highlighted that China was the major contributor to the first spread peak, while multiple regions contributed to the second spread peak, with Europe being the dominant source. We further studied the viral importation events for major continental regions. The network-based SEIR modelling revealed two distinct peaks of COVID-19 importation events in most continents The Bayesian inference analyses also found that viral exportations from China peaked during mid-to late January, and dropped sharply after the shutdown of Wuhan ( Figure 3A ). In contrast, exportations from Europe rapidly increased from mid-February and peaked in early March. During this period, the virus migration frequency from Europe to North America and Oceania was estimated to have increased until the WHO declared COVID-19 a pandemic on March 11 ( Figure 3B ). Additionally, virus diffusions from Europe to North America were likely to have already occurred before travel restrictions on European citizens were implemented by the USA on March 13, 2020. However, since March 26, 2020, shortly after the second transmission peak, the USA has been the country with the highest reported number of COVID-19 cases. However, in the second intercontinental dispersal phase, the seeding of viruses was exaggerated by population movements between countries outside of China from late February through mid-March, which finally led to the global pandemic. In particular, our study identified Europe as an epicenter of this phase through phylogenetic analyses, which is consistent with other studies that revealed the dominant strains circulating in the USA and the UK before travel restrictions were imported from continental Europe where community transmission was widespread. 19, 21, 35, 36 The USA, as the most-affected country, had substantial airline network connections to Europe but imposed relatively late travel restrictions on European travellers. Our phylogenetic analyses revealed the dominant strains in seven out of ten states with the highest case numbers were imported from Europe in the second phase, rather than from China in the first phase, which was in accordance with the results from epidemiological modelling and further highlighted the role of international travel from Europe in SARS-CoV-2 spread into the USA and Our findings should be considered in the context of several assumptions and data limitations. First, we only estimated the spread risk of COVID-19 via air travel here due to data availability. With the integration of land and sea transport models, the international travel networks are more All authors read and approved the manuscript. Funding This work was supported by Key research and development project of Shandong province Strategic Priority Research Programme of the Chinese Academy of Sciences [XDB29010102 and XDA19090118]; National Natural Science Foundation of China (NSFC) [32041010 and 81773498]; National Science and Technology Major Project of China Bill & Melinda Gates Foundation European Union Horizon 2020 [MOOD 874850]; National Major Project for Control and Prevention of Infectious Disease in China Youth Innovation Promotion Association of CAS ); the Clinton Health Access Initiative, the UK Department for International Development (DFID) and the Wellcome Trust 204613/Z/16/Z to A ]; the Academic Promotion Programme of Shandong First Medical University A pneumonia outbreak associated with a new coronavirus of probable bat origin Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding WHO Coronavirus Disease (COVID-19) Assessing the impact of coordinated COVID-19 exit strategies across Europe Assessing spread risk of COVID-19 within and beyond China Effect of non-pharmaceutical interventions to contain COVID-19 in China An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in china Correlation between travellers departing from Wuhan before the Spring Festival and subsequent spread of COVID-19 to all provinces in China Quantifying the association between domestic travel and the exportation of novel coronavirus (2019-nCoV) cases from Wuhan, China in 2020: a correlational analysis The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak Estimating COVID-19 outbreak risk through air travel Tracking the spread of COVID-19 in India via social networks in the early phase of the pandemic Routes for COVID-19 importation in Brazil European Centre for Disease Prevention and Control. Resurgence of reported cases of COVID-19 in the EU/EEA, the UK and EU candidate and potential candidate countries Potential for inter-state spread of Covid-19 from Analysis of mobile device-location and commercial flight data Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study Using observational data to quantify bias of traveller-derived COVID-19 prevalence estimates in Wuhan Euro surveillance: bulletin Europeen sur les maladies transmissibles = Detection and Genetic Characterization of Community-Based SARS-CoV-2 Infections Genomic surveillance reveals multiple introductions of SARS-CoV-2 into Northern California Preliminary analysis of SARS-CoV-2 importation & establishment of UK transmission lineages Impact of international travel and border control measures on the global spread of the novel 2019 coronavirus outbreak The R0 package: a toolbox to estimate reproduction numbers for epidemic outbreaks United Nations Office for the Coordination of Humanitarian Affairs, ACAPS COVID-19: Government Measures Dataset Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia Google COVID-19 community mobility reports: anonymization process description (version 1.0) 2020 MAFFT multiple sequence alignment software version 7: Improvements in performance and usability Bayesian phylogenetic and phylodynamic data integration using BEAST 1.10 RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies On the origin and continuing evolution of SARS-CoV-2 A dynamic nomenclature proposal for SARS-CoV-2 to assist genomic epidemiology Introductions and early spread of SARS-CoV-2 in the New York city area Cryptic transmission of sars-cov-2 in Washington state The origin and early spread of SARS-CoV-2 in Europe Evidence for limited early spread of COVID-19 within the United States National Health Commission of the People's Republic of China. Situation report of COVID-19 in China Resurgence of COVID-19 in Japan World Health Organization Genetic tracing of HCoV-19 for the re-emerging outbreak of COVID-19 in Beijing Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region Effect of changing case definitions for COVID-19 on the epidemic curve and transmission parameters in mainland China: a modelling study The impact of COVID-19 and strategies for mitigation and suppression in low-and middle-income countries The effect of large-scale anti-contagion policies on the COVID-19 pandemic Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe The effectiveness of full and partial travel bans against COVID-19 spread in Australia for travellers from China during and after the epidemic peak in China Effectiveness of interventions targeting air travellers for delaying local outbreaks of SARS-CoV-2 We thank the important work of SARS-CoV-2 genome data producers globally contributing sequence data to the GISAID, NCBI GenBank, NMDC, and NGDC databases. We also acknowledge Google and Baidu for sharing publicly available population mobility data. The authors have declared no conflicts of interest.